Real-world experience of ocrelizumab in multiple sclerosis in an Arab population

B Garcia-Cañibano, S Ouanes… - Journal of Drug …, 2021 - Taylor & Francis
Objective Pivotal clinical trials revealed good clinical efficiency of ocrelizumab while having
a good safety profile in the management of multiple sclerosis (MS). However, real-world data …
被引用次数：8 相关文章
[HTML] nih.gov

[HTML][HTML] Real-world experience of ocrelizumab in multiple sclerosis in an Arab population

B Garcia-Cañibano, S Ouanes… - Journal of Drug …, 2021 - ncbi.nlm.nih.gov
Objective Pivotal clinical trials revealed good clinical efficiency of ocrelizumab while having
a good safety profile in the management of multiple sclerosis (MS). However, real-world data …

Real-world experience of ocrelizumab in multiple sclerosis in an Arab population

B Garcia-Cañibano, S Ouanes… - Journal of drug …, 2021 - pubmed.ncbi.nlm.nih.gov
Objective Pivotal clinical trials revealed good clinical efficiency of ocrelizumab while having
a good safety profile in the management of multiple sclerosis (MS). However, real-world data …
[PDF] academia.edu

[PDF][PDF] Real-world experience of ocrelizumab in multiple sclerosis in an arab population

B Garcia-Cañibano, S Ouanes, G Ganesan, W Yousuf… - 2021 - academia.edu
Objective: Pivotal clinical trials revealed good clinical efficiency of ocrelizumab while having
a good safety profile in the management of multiple sclerosis (MS). However, real-world data …

Real-world experience of ocrelizumab in multiple sclerosis in an Arab population.

B Garcia-Cañibano, S Ouanes… - Journal of Drug …, 2021 - europepmc.org
Objective Pivotal clinical trials revealed good clinical efficiency of ocrelizumab while having
a good safety profile in the management of multiple sclerosis (MS). However, real-world data …